Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

2019/07/24 by Kayvon Modjarrad, Christine C. Roberts, Christine C Roberts +53 · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Intramuscular injections and effects #SARS-CoV-2 and COVID-19 Research #vaccines and immunoinformatics approaches

paper · pdf · doi:10.1016/s1473-3099(19)30266-x

openalex publication_date 2019/07/24 · crossref created 2019/07/24 · crossref issued 2019/09/01 · crossref published 2019/09/01 · crossref published-print 2019/09/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/26 · crossref indexed 2026/06/18 · openalex updated_date 2026/08/01

Citations

• Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Cited by

• Coronavirus vaccine development: from SARS and MERS to COVID-19
• The success of SARS-CoV-2 vaccines and challenges ahead
• Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
• Prospects for a safe COVID-19 vaccine
• COVID-19 vaccine [wikipedia]